Retreatment
Research News and Information

Monday, November 23, 2009

Critical organ preservation in reirradiation brachytherapy by injectable spacer.

29 Sep 2009 PURPOSE: This case series study evaluated the feasibility and effectiveness of an interstitial high-dose rate brachytherapy (HDR-BT) procedure combined with an at-risk organ-sparing procedure. METHODS AND MATERIALS: Thirty patients who were ... Read more...

Vinflunine in platinum-pretreated patients with locally advanced or metastatic urothelial carcinoma: results of a large phase 2 study.

13 Sep 2009 BACKGROUND: The activity and safety of vinflunine was evaluated in patients with locally advanced or metastatic urothelial carcinoma (UC) who developed disease progression within 12 months of platinum-containing chemotherapy. METHODS: Patients with ... Read more...

Phase 2 trial of sorafenib in patients with advanced urothelial cancer: a trial of the Eastern Cooperative Oncology Group.

13 Sep 2009 BACKGROUND: There is no effective second-line systemic chemotherapy for patients with disease progression after cisplatin-based chemotherapy. A phase 2 trial of sorafenib was performed to determine the activity and toxicity of this agent in a ... Read more...

Latest indexed articles for 'Retreatment'

These are the very latest articles for this heading:

• Intravitreal ranibizumab as primary treatment for neovascular membrane associated with idiopathic juxtafoveal retinal telangiectasia. 30 Oct 2009
• Medical image. Combined surgery and repeated angioembolisation for a post-pancreatitis pseudoaneurysm. 7 Oct 2009
• Critical organ preservation in reirradiation brachytherapy by injectable spacer. 29 Sep 2009
• [Established eradication therapy fails. What will eliminate Helicobacter now?] 22 Sep 2009
• Vinflunine in platinum-pretreated patients with locally advanced or metastatic urothelial carcinoma: results of a large phase 2 study. 13 Sep 2009
• Phase 2 trial of sorafenib in patients with advanced urothelial cancer: a trial of the Eastern Cooperative Oncology Group. 13 Sep 2009
• Ultrastructural examination of failed molar retreatment with secondary apical periodontitis: an examination of endodontic biofilms in an endodontic retreatment failure. 30 Aug 2009
• Defining success after surgery for pelvic organ prolapse. 30 Aug 2009
• Endoimplantology: part 2, surgical classifications. 30 Aug 2009
• Chronic lymphocytic leukemia: treatment options for patients with refractory disease. 30 Aug 2009
• Dynamics and management of cytopenias associated with dasatinib therapy in patients with chronic myeloid leukemia in chronic phase after imatinib failure. 30 Aug 2009
• Management of fluocinolone implant dissociation during implant exchange. 30 Aug 2009
• SCOREing in retinal venous occlusive disease. 30 Aug 2009
• A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. 30 Aug 2009
• A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. 30 Aug 2009
• Diabetic macular edema. 30 Aug 2009
• Tachyphylaxis and bevacizumab. 30 Aug 2009
• Return to sender hospital readmission after percutaneous coronary intervention. 30 Aug 2009
• All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients. 30 Aug 2009
• Repair of bronchial esophageal fistula using Alloderm. 30 Aug 2009

See a longer list of these articles.

Technical information about 'Retreatment'

Definition: The therapy of the same disease in a patient, with the same agent or procedure repeated after initial treatment, or with an additional or alternate measure or follow-up. It does not include therapy which requires more than one administration of a therapeutic agent or regimen. Retreatment is often used with reference to a different modality when the original one was inadequate, harmful, or unsuccessful.

Descriptor UI: D019233

Alternative terms: Retreatment; Retreatments;

Related Mesh Headings: Reoperation;

Allowable Qualifiers: adverse effects; classification; economics; history; instrumentation; methods; mortality; nursing; psychology; standards; trends; utilization; veterinary; statistics & numerical data; contraindications; ethics;

Tree Number: E02.887;

History Note: 97

Technical Notes: NIM; coord with specific type of ther (IM) + specific disease /ther (or other ther qualif) (IM)